Navigation Links
Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
Date:2/12/2013

RARITAN, N.J., Feb. 12, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen), today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designations for the investigational oral agent ibrutinib as a monotherapy for two B-cell malignancies: in patients with relapsed or refractory mantle cell lymphoma (MCL) who have received prior therapy, and in patients with Waldenstrom's macroglobulinemia (WM).

Enacted as part of the 2012 FDA Safety and Innovation Act (FDASIA), Breakthrough Therapy Designation is intended to expedite the development and review time for a potential new medicine "to treat a serious or life-threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development."[1]

"We are pleased that the FDA has granted two Breakthrough Therapy Designations for ibrutinib as the designation represents a major leap forward in accelerating drug development timelines," said Paul Stoffels , M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. "We are committed to realizing the full potential of ibrutinib for patients with mantle cell lymphoma, Waldenstrom's macroglobulinemia, as well as other B-cell malignancies, and will work with Pharmacyclics and the FDA to ensure the clinical development program for ibrutinib continues to move forward as quickly as possible."

Janssen Biotech, Inc. and Pharmacyclics entered a collaboration and license agreement in December 2011 to co-develop and co-commercialize ibrutinib. T
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
2. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
3. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
4. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
5. Remique (TM), a Revolutionary Dietary Supplement, Manufactured in FDA Registered Facilities, Receives Raves from Compromised Immune System Sufferers
6. Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits
7. Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
8. Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
9. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
10. Virtual Ports Receives Patent Approvals in the United States and Japan
11. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Type of Material, by Technology, by Application & by Region- ... offering. The demand for membranes is estimated ... the market to $29.31 billion Membrane technology was ... such as water filtration and kidney dialysis. In modern times, ...
(Date:8/19/2014)... NEW YORK , Aug. 19, 2014 ... the crucial component needed to make Big Data in ... drive system sales.  As part of the American Recovery ... to electronic medical record (EMR) projects and penalties will ... Kalorama Information, in its complete study of ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
... Dec. 3 Stryker Corporation (NYSE: SYK ) announced ... repurchase up to $750 million of its common stock. The ... the Company,s management based on their evaluation of market conditions, stock ... Purchases may be made from time to time in the ...
... , , MARQUETTE, Mich., Dec. 3 ... innovative medical devices, received 2 awards in the Cervical ... gala held recently in San Francisco, California in conjunction ... Pioneer Surgical,s next generation technologies receiving awards were the ...
Cached Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Pioneer(R) Surgical Technology, Inc. Receives Prestigious Spine Technology Awards 2
(Date:8/20/2014)... Over 31 million Americans suffer from low ... back pain is the single leading cause of disability worldwide, ... work. Americans spend at least $50 billion each year trying ... back pain are not due to organic conditions such as ... Pete, a busy accountant, had little time for physical activity ...
(Date:8/19/2014)... 2014 The elegant bamboo floorings from ... their houses in an environmentally conscious way with the ... materials and have an aluminum oxide finish to help ... for high-traffic areas. , Recently, the company has released ... floorings . These fresh items are specially made for ...
(Date:8/19/2014)... well-known bamboo product manufacturer and retailer, has unveiled its new ... excited to reveal the new items, and it has decided ... every customer can get a discounted price, up to 30 ... , The company’s deckings are made of the finest quality, ... are perfect for a dining room, living room, kitchen, foyer, ...
(Date:8/19/2014)... 2014 For decades it has been ... chiropractic adjustments are dangerous and cause strokes, cervical artery ... they do not recommend chiropractic to their patients. Now ... do refer to chiropractors because they have read the ... new research has popped up that tries to cast ...
(Date:8/19/2014)... St. Petersburg, FL (PRWEB) August 20, 2014 ... in skin care? What can soften skin, replenish and nourish ... from Sublime Beauty®. , "Client after client raves about ... mask," says Kathy Heshelow, founder of Sublime Beauty®. "The ... is easy to use. Simply smooth it over cleansed ...
Breaking Medicine News(10 mins):Health News:Physical Therapists Learn to Relieve Low Back Pain 2Health News:BambooIndustry.com Announces Up To 30% Discount On Its New Click Strand Woven Bamboo Floorings 2Health News:Promotional Bamboo Deckings from Well-known Online Supplier BambooIndustry.com 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 2Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 3Health News:Is It True That the Chiropractor Can Cause a Stroke? Dr. Harbison of AlignLife Wood River Speaks Up 4Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2
... commercials, print ads and a new website, OWINGS MILLS, ... announced that the Company will unveil a new advertising,campaign featuring ... of the campaign will be celebrity spokeswoman Genie Francis, who,reached ... few months on the,Medifast Program. Francis is best known to ...
... aggressive than 20 years ago, studies find , WEDNESDAY, Dec. ... be more persistent and harder to outgrow than they were ... from the Johns Hopkins Children,s Center, researchers followed more than ... egg allergy for more than 13 years. , They ...
... daily,"Profile America" feature from the U.S. Census Bureau:, ... America -- Wednesday, December 26th. One of the most ... years ago,the mapping of the first human chromosome. Since ... have been blueprinted, allowing,researchers to study the genes they ...
... that long ago that,pharma companies were growing their sales ... the pharma industry companies are now,shrinking their sales forces. ... flux, the fundamentals of selling remain constant: planning,targeting, relationship ... practices that reps follow within these broad areas that,separate ...
... Shareholders of Subsidiary to Invest in Nyer Medical Group;, ... Nyer Medical Group, BANGOR, Maine, Dec. 26 ... that it has reached agreement with the,minority shareholders of ... remaining 20% interest in the pharmacy chain in,fulfillment of ...
... and Their Parents to Enjoy Flexible Purchasing ... Benefits of Healthcare Gift Card, PITTSBURGH, ... it plans to present the year,s first,newborns with Prepaid Healthcare Visa(R) ... way to cover,the many costs associated with, among other life events, ...
Cached Medicine News:Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 2Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 3Health News:Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008 4Health News:Fewer Children Outgrowing Allergies to Milk, Eggs 2Health News:Pharmaceutical Sales: Best Practices for Pharmaceutical Sales Success 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 2Health News:Nyer Medical Group Reaches Agreement to Acquire Minority Interest in Pharmacy Chain Subsidiary 3Health News:Highmark to Present State's Newest Residents with Healthcare Gift Cards 2
... articulating (22° and 45° in both directions) ... resection, transection and anastomosis for open surgery ... two triple-staggered rows of staples and simultaneously ... The instrument is designed for multiple use ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... The Auto Suture™ POLY GIA™ ... two, double staggered rows of LACTOMER™ ... the tissue between the two, double ... GIA™ 75-.060 single use surgical stapler ...
... ILA™ 75 single-use stapler, anastomotic type, ... resection, transection, and/or the anastomosis of ... The ILA™ 75 single-use stapler, anastomotic ... the resection, transection, and/or the anastomosis ...
Medicine Products: